Cart
sales@molnova.com
[SER140]-PLP(139-151) TFA
CAS No. ———
[SER140]-PLP(139-151) TFA( ——— )
Catalog No. M40590 CAS No. ———
[SER140]-PLP(139-151) (TFA) is a polypeptide fragment of the myelin lipid protein.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name[SER140]-PLP(139-151) TFA
-
NoteResearch use only, not for human use.
-
Brief Description[SER140]-PLP(139-151) (TFA) is a polypeptide fragment of the myelin lipid protein.
-
Description[SER140]-PLP(139-151) (TFA) is a polypeptide fragment of the myelin lipid protein.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Myosin Kinase Inhibi...
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.
-
Oxyresveratrol-4,3,5...
Oxyresveratrol-4,3',5'-tri-O-β-D-glucopyranoside
-
CI-976
CI-976 (PD 128042) is a potent, selective, orally bioavailable inhibitor of ACAT-1 (Acetyl-CoA acetyltransferase 1) with IC50 of 73 nM.
